BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 28763457)

  • 1. RORγt and RORα signature genes in human Th17 cells.
    Castro G; Liu X; Ngo K; De Leon-Tabaldo A; Zhao S; Luna-Roman R; Yu J; Cao T; Kuhn R; Wilkinson P; Herman K; Nelen MI; Blevitt J; Xue X; Fourie A; Fung-Leung WP
    PLoS One; 2017; 12(8):e0181868. PubMed ID: 28763457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic inhibition of RORγt regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo.
    Skepner J; Ramesh R; Trocha M; Schmidt D; Baloglu E; Lobera M; Carlson T; Hill J; Orband-Miller LA; Barnes A; Boudjelal M; Sundrud M; Ghosh S; Yang J
    J Immunol; 2014 Mar; 192(6):2564-75. PubMed ID: 24516202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered Expression of Specific Transcription Factors of Th17 (RORγt, RORα) and Treg Lymphocytes (FOXP3) by Peripheral Blood Mononuclear Cells from Patients with Multiple Sclerosis.
    Etesam Z; Nemati M; Ebrahimizadeh MA; Ebrahimi HA; Hajghani H; Khalili T; Frootan R; Zinoddini N; Jafarzadeh A
    J Mol Neurosci; 2016 Sep; 60(1):94-101. PubMed ID: 27370539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonizing Retinoic Acid-Related-Orphan Receptor Gamma Activity Blocks the T Helper 17/Interleukin-17 Pathway Leading to Attenuated Pro-inflammatory Human Keratinocyte and Skin Responses.
    Ecoeur F; Weiss J; Kaupmann K; Hintermann S; Orain D; Guntermann C
    Front Immunol; 2019; 10():577. PubMed ID: 30972071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoflavones enhance interleukin-17 gene expression via retinoic acid receptor-related orphan receptors α and γ.
    Kojima H; Takeda Y; Muromoto R; Takahashi M; Hirao T; Takeuchi S; Jetten AM; Matsuda T
    Toxicology; 2015 Mar; 329():32-9. PubMed ID: 25583575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical and clinical characterization of the RORγt inhibitor JNJ-61803534.
    Xue X; De Leon-Tabaldo A; Luna-Roman R; Castro G; Albers M; Schoetens F; DePrimo S; Devineni D; Wilde T; Goldberg S; Kinzel O; Hoffmann T; Fourie AM; Thurmond RL
    Sci Rep; 2021 May; 11(1):11066. PubMed ID: 34040108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand.
    Solt LA; Kumar N; Nuhant P; Wang Y; Lauer JL; Liu J; Istrate MA; Kamenecka TM; Roush WR; Vidović D; Schürer SC; Xu J; Wagoner G; Drew PD; Griffin PR; Burris TP
    Nature; 2011 Apr; 472(7344):491-4. PubMed ID: 21499262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased peripheral RORα and RORγt mRNA expression is associated with acute-on-chronic hepatitis B liver failure.
    Qi ZX; Wang LY; Fan YC; Zhang JJ; Li T; Wang K
    J Viral Hepat; 2012 Nov; 19(11):811-22. PubMed ID: 23043388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription factor RORα enforces stability of the Th17 cell effector program by binding to a Rorc cis-regulatory element.
    Hall JA; Pokrovskii M; Kroehling L; Kim BR; Kim SY; Wu L; Lee JY; Littman DR
    Immunity; 2022 Nov; 55(11):2027-2043.e9. PubMed ID: 36243007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The AP-1 transcription factor JunB is required for Th17 cell differentiation.
    Yamazaki S; Tanaka Y; Araki H; Kohda A; Sanematsu F; Arasaki T; Duan X; Miura F; Katagiri T; Shindo R; Nakano H; Ito T; Fukui Y; Endo S; Sumimoto H
    Sci Rep; 2017 Dec; 7(1):17402. PubMed ID: 29234109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Distinct Inhibitory Function for miR-18a in Th17 Cell Differentiation.
    Montoya MM; Maul J; Singh PB; Pua HH; Dahlström F; Wu N; Huang X; Ansel KM; Baumjohann D
    J Immunol; 2017 Jul; 199(2):559-569. PubMed ID: 28607111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Jagged-1 signaling suppresses the IL-6 and TGF-β treatment-induced Th17 cell differentiation via the reduction of RORγt/IL-17A/IL-17F/IL-23a/IL-12rb1.
    Wang Y; Xing F; Ye S; Xiao J; Di J; Zeng S; Liu J
    Sci Rep; 2015 Feb; 5():8234. PubMed ID: 25648768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AT-rich-interactive domain-containing protein 5A functions as a negative regulator of retinoic acid receptor-related orphan nuclear receptor γt-induced Th17 cell differentiation.
    Saito Y; Kagami S; Sanayama Y; Ikeda K; Suto A; Kashiwakuma D; Furuta S; Iwamoto I; Nonaka K; Ohara O; Nakajima H
    Arthritis Rheumatol; 2014 May; 66(5):1185-94. PubMed ID: 24782182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and pharmacological inhibition of the nuclear receptor RORα regulates T
    Wang R; Campbell S; Amir M; Mosure SA; Bassette MA; Eliason A; Sundrud MS; Kamenecka TM; Solt LA
    Nat Commun; 2021 Jan; 12(1):76. PubMed ID: 33397953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small molecules targeting RORγt inhibit autoimmune disease by suppressing Th17 cell differentiation.
    Tan J; Liu H; Huang M; Li N; Tang S; Meng J; Tang S; Zhou H; Kijlstra A; Yang P; Hou S
    Cell Death Dis; 2020 Aug; 11(8):697. PubMed ID: 32829384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing RORγt in Human CD4
    Shi X; Song P; Tao S; Zhang X; Chu CQ
    Sci Rep; 2019 Jul; 9(1):10375. PubMed ID: 31316164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo regulation of gene expression and T helper type 17 differentiation by RORγt inverse agonists.
    Skepner J; Trocha M; Ramesh R; Qu XA; Schmidt D; Baloglu E; Lobera M; Davis S; Nolan MA; Carlson TJ; Hill J; Ghosh S; Sundrud MS; Yang J
    Immunology; 2015 Jul; 145(3):347-56. PubMed ID: 25604624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small molecule allosteric inhibitors of RORγt block Th17-dependent inflammation and associated gene expression in vivo.
    Saenz SA; Local A; Carr T; Shakya A; Koul S; Hu H; Chourb L; Stedman J; Malley J; D'Agostino LA; Shanmugasundaram V; Malona J; Schwartz CE; Beebe L; Clements M; Rajaraman G; Cho J; Jiang L; Dubrovskiy A; Kreilein M; Shimanovich R; Hamann LG; Escoubet L; Ellis JM
    PLoS One; 2021; 16(11):e0248034. PubMed ID: 34752458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of RORγt activity and Th17 differentiation by a set of novel compounds.
    Ding Q; Zhao M; Bai C; Yu B; Huang Z
    BMC Immunol; 2015 May; 16():32. PubMed ID: 26021566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bob1 enhances RORγt-mediated IL-17A expression in Th17 cells through interaction with RORγt.
    Ikegami I; Takaki H; Kamiya S; Kamekura R; Ichimiya S
    Biochem Biophys Res Commun; 2019 Jul; 514(4):1167-1171. PubMed ID: 31103264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.